We found that these subpopulations have a decreased expression of TACI in SLE patients compared to HS, DN2 (28.25% vs 44.0%, p = 0.0153) and aNAV (39.55% vs 53.8%, p = 0.0020) (Figures 3I, J). The gene discussed is TNFRSF13B; the disease is systemic lupus erythematosus.